AIM Fintech Glantus Holdings successfully rolling out buy & build strategy says CEO Maurice Healy. Watch the full video here.
Exmex posted this link this morning.
Statement from the South African president yesterday.
Boris would do well to cut and paste this into his address this afternoon.
Direct delivery of an important message.
Poidster - Fri 19:28
"Further digging finds that these are not just covid testing centres but opening up the whole of diagnostics away from the acute hospital setting, that said, they will be offering pathology services and its a near patient testing environment which falls right into novacyts remit. This is a £10 billion contract, lots to play for and novacyt must be a contender for this opportunity"
The following seems relevant to your research:
15.06.2020 - https://www.gov.uk/government/publications/how-tests-and-testing-kits-for-coronavirus-covid-19-work/target-product-profile-point-of-care-sars-cov-2-detection-tests
The purpose of a Target Product Profile (TPP)
Target product profiles (TPP) outline the desired ‘profile’ or characteristics of a target product that is aimed at a particular disease or diseases. TPPs state intended use, target populations and other desired attributes of products, including safety and performance-related characteristics. They help guide industry development towards desired characteristics. A TPP provides a common foundation for the development of tests and contains sufficient detail to allow device developers and key stakeholders to understand the characteristics a test must have to be successful for the particular intended use. Included is a description of (1) the preferred and (2) the minimally acceptable profiles based on the intended use, setting of use, and intended user, with respect to the performance and operational characteristics expected of the target products. As new scientific evidence is generated, this TPP may require further review and revision.
Also this 19.06.2021 document:
TARGET PRODUCT PROFILE
In Vitro Diagnostic (IVD) self-tests for the detection of SARS-CoV-2 in people without symptoms
Are we going to see an RNS on EACH occasion a Primerdesign product is CTDA approved?
Why not, - lets see if the arrival of DA makes a little difference or a lot.
This morning's price action is unsurprising with the worldwide virus and variant news
the way it is, and only 70 Mil shares in issue.
Lets hope WHO doesn't tarry too long over making B.1.1.529 a VOC, or at least a VUI, for everybody's sake.
From : https://www.thesun.co.uk/health/16849417/new-covid-variant-infecting-vaccinated/
This article discusses the new B.1.1.529 'Botswana' variant with 32 mutations.
"The new variant has mutations K417N and E484A that are linked to those in previous strains that were able to dodge vaccines.
**(Please Note K417N detected by SNP-sig assay EscapePLEX)**.
And it also has the N440K, found on Delta, and S477N, on the New York variant, linked to antibody escape.
It also has the mutation N501Y that makes viruses more transmissible and was previously seen on the fast-spreading Alpha variant."
**(Please note N501Y detected by SNP-sig VariPLEX)**.
So Primerdesign already detects some of B.1.1.529's mutations, but in different SNP-sig assay's.
They might now be developing B.1.1.529 mutation detection in one single new SNP-sig product?
From SKY news, Thursday 25 November 2021 23:22, UK:
'The WHO may decide to upgrade it a variant of concern (VOC) - on par with established variants like Delta, meaning it has "global public health significance" - and issue guidance to member countries.
It may also classify it a less serious variant of interest (VOI), which indicates for example that it may affect transmissibility or disease severity.'
So WHO are yet to designate B.1.1.529 it seems.
Not mentioned as a Australia / NZ distributor in spreadsheet.
In-Vitro Technologies :
https://diagnostic.invitro.com.au/l/primerdesign/endofyear - product discounts available
https://lifescience.invitro.com.au/about-us/ - staffing - many new starts this year
Unclear how long In-Vitro Technologies have been working with Novacyt.
Hit 'Diagnostic' and 'Life Sciences' at top of screen for access to Novacyt products.
This is not a small company, and is ambitious.
1 Have checked previous RNS's - they do not contain "authorisation of a Molecular Test Kit for S.A."
2 https://www.pssa.org.za/download/list-authorised-serology-antibody-test-kits.pdf issued by South African Health Products Regulatory Authority, - License Holder Celtic Molecular Diagnostics (Pty) Ltd.
Celtic sell our instruments and assays from a Cape Town base, and appear to be the license holder for a South African Molecular test kit authorisation. - Unsure how long this has been the case, but this status is not reflected in the spreadsheet which stopped being updated in May 2021.
22.11.2021 - German Virus Test Kits Run Low as People Stock Up for Next Wave
Surely we are getting some of the action if Germany is one of our better markets?
I posted this on 10.02.2021, when a Porky accusation caused poster ShaunP to:
a stop posting
b stop collating the spreadsheet he had developed, mainly containing the research posters here had reported.
ShaunP restarted posting / collating about a month later.
This 10th Feb post has been deleted, sorry about date confusion.
Extracted from today's Daily Mail - 'Platell's People':
Interesting Point of View:
"Around 10,000 more people have died in the past four months from non-Covid conditions like heart disease as their treatment was postponed. Why?
Because NHS wards are now full of selfish deluded, unvaccinated patients who caught Covid.
Have these bed blockers no shame?
They've caused unimaginable suffering, to the families of those who did the right thing yet were put at the back of the queue for emergency treatment. A plague on all these selfish idiots."
This doesn't need to be the case.
Those with non-Covid conditions who are probably on a waiting list, should have the NHS treatment the NHS planned for them.
This can be achieved by passing the unvaccinated who have contracted covid-19 to private health care.
They would be provided with the same care they would have received in a NHS hospital, until they are well enough to go home.
Private care should be provided entirely at the patients expense, with no government assistance.
No jabs / booster jabs, no NHS care.
Nobody will have the balls to implement this, - but it should spark an incendiary human rights debate!
Any thoughts Kier?
"On one hand you want sentiment to come back but for that to happen covid needs to run wild"
It doesn't need to run wild, it just needs to be prevalent enough to swamp the NHS.
That very nearly happened recently, it's one of the high water marks for the government in monitoring this virus.
BYP - I tried hard to not engage with Porky here.
I had this to say to Porky in June last year.
"If there was a Strengths, Weaknesses, Opportunities, and Threats (SWOT) analysis of this board Porky, you would be my one and only Threat.
The damage and evil intent you are capable of, and the misleading assumptions you very often make, are a clear and present danger to other posters prosperity.
Some rely on the relentless enthusiasm and the repetition evident in your posts to keep them invested in this share, - they have admitted as much.
With the foregoing, that is a very dangerous state of affairs.
Porky you have neither honour, nor dignity.
Fellow posters would be well advised to treat anything Porky says with with a ton of salt."
That turned out to be too hot for Porky disciples on this bb.
New posters would do well to treat anyone posting with apparently limitless optimism with caution in future.
Footnote, - it turned out he was a danger to his own investment strategy, losing big time.
An Introduction to Contract for Differences (CFDs)
I agree Rcdm, however the public aren't focused on the number of people catching the virus, they only focus on the numbers dying.
As vaccines have broken the link between the numbers infected and consequent large numbers of deaths, there is less incentive for the public to continue 'hands, face, space' precautions. ie Everything is normal again.
IMO this winter, there are going to be a large amount of infections and no decrease in testing activity.